Pan Drugs Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 08-12-2024
- Paid Up Capital ₹ 3.14 Cr
as on 08-12-2024
- Company Age 31 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.84 M
as on 08-12-2024
- Satisfied Charges ₹ 45.08 Cr
as on 08-12-2024
- Revenue -18.99%
(FY 2023)
- Profit 2162.05%
(FY 2023)
- Ebitda -72.78%
(FY 2023)
- Net Worth 191.08%
(FY 2023)
- Total Assets -36.75%
(FY 2023)
About Pan Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 3.14 Cr.
The company currently has active open charges totaling ₹2.84 M. The company has closed loans amounting to ₹45.08 Cr, as per Ministry of Corporate Affairs (MCA) records.
Parag Raval, Kamal Pandya, Atul Pandya, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ1993PLC020671
- Company No.
020671
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Nov 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pan Drugs Limited offer?
Pan Drugs Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Cardiovascular Drugs & Medication, Diabetes Medicine, Anti Cancer Injection, Common Disease Medicines, Thyroxine Sodium Tablets, Hair Growth Medicine, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs.
Who are the key members and board of directors at Pan Drugs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parag Raval  | Director | 10-May-2018 | Current |
| Kamal Pandya | Director | 16-Nov-1993 | Current |
| Atul Pandya | Director | 31-Jul-2007 | Current |
| Hemant Upadhyay | Director | 31-May-2003 | Current |
Financial Performance and Corporate Structure Insights of Pan Drugs.
Pan Drugs Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.99% decrease. The company also saw a substantial improvement in profitability, with a 2162.05% increase in profit. The company's net worth Soared by an impressive increase of 191.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pan Drugs?
In 2023, Pan Drugs had a promoter holding of 43.56% and a public holding of 56.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Jiarzu Pharmavit Private LimitedActive 11 months 6 days
Kamal Pandya and Atul Pandya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Dec 2021 | ₹2.84 M | Open |
State Band Of Hydrabad Creation Date: 20 Oct 2001 | ₹3.00 Cr | Satisfied |
Anyonya Co - Operative Bank Ltd. Creation Date: 13 Sep 2000 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Pan Drugs?
Pan Drugs has a workforce of 34 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pan Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pan Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
